FDA approves new drug for acute myeloid leukemia
On Sept. 1, the U.S. Food and Drug Administration (FDA) approved Mylotarg (gemtuzumab ozogamicin) for the treatment of adults with newly diagnosed acute myeloid leukemia whose tumors express…
Reader Survey
Please share your feedback! We’re interested to learn more about your experience with American Nurse Journal.
